Decode the Vial Label and Confirm the Batch Before Sharing Stock
When two colleagues will share the same stock, the weakest point is often not the analytical science but the paperwork handover. A vial can be moved between benches, photographed for a shared folder, or split between workstations, and within a few days the label reference may be the only reliable bridge between the physical material and the batch CoA. Treat that reference as the primary identifier, not the product name alone and certainly not the cap colour or the folder name chosen by whoever received the delivery.
Research Sciences describes its vial labels as using a reference format that combines the SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. The precise characters matter: the product code, the hyphen, the month and year, and the slash should all be transcribed exactly. A shortened version such as “BPC10” may identify the catalogue item, but it does not necessarily identify the batch documentation that belongs to that vial. Before stock is shared, one colleague should read the label aloud while the other checks the CoA file, then both should confirm the reference matches character for character.
The CoA should be the batch-specific document supplied with the material, not a generic product page or an old certificate stored under a similar name. Research Sciences states that every product includes a CoA for HPLC purity and identity, and the FAQ position is that exact purity is stated on the CoA. Researchers should open the actual batch document and check the product name, reference and test details rather than relying on a headline figure. The homepage lists claims such as ≥99% Verified Purity and CoAs Janoshik Analytical Reports; these are the shop’s current published wording and should be reconfirmed on the live site and, where relevant, on the batch CoA.
Cap colours and other packaging details may vary and are not an indicator of identity, analytical quality or manufacturing origin. If a label is missing or ambiguous, catalogue pages, including those for Uk peptides, can help confirm product-family naming, but they do not replace the batch CoA. All materials remain strictly for controlled laboratory and analytical research, and they are not for human or veterinary use. Good label discipline is therefore not administrative tidiness; it is part of keeping the stock inside a lawful, traceable in-vitro workflow.
Create a Shared Stock Register That Connects Reference, CoA and Custody
Two colleagues sharing one stock need a register that is simple enough to maintain and specific enough to survive staff changes, freezer reorganisation or a busy week of assays. The register should record the vial label reference, catalogue product name, quantity received, date received, storage location, CoA file name, expiry date, current custodian and any colleague authorised to draw from the stock. The reference field should be copied from the vial, not retyped from memory, and the CoA should be stored in a read-only folder with a file name that begins with the same reference. This creates a clear link between the physical vial and the batch document.
Do not assume that a matching Internal Test Reference, or ITR, means two deliveries are interchangeable. The shop’s FAQs state that restocked products may carry the same ITR as earlier stock; an ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. The register should therefore record the vial label reference and the batch CoA file, not the ITR alone. Where two colleagues are sharing stock from different deliveries, keep the vials physically separated until each has been reconciled to its own CoA.
Storage records belong in the same handover. Research-use-only peptides are typically supplied lyophilised and should be stored at –20°C or below, sealed with desiccant and protected from moisture, heat and light, avoiding repeated freeze–thaw cycles. If a vial is reconstituted for an in-vitro assay, record the diluent volume and target concentration for that laboratory workflow, and note that reconstituted material is less stable and should be held at 2–8°C for short-term laboratory use. This information supports reproducibility, but it does not convert the material into a medicine, medical device, injectable, treatment or food supplement under UK law, and the materials are not for human or veterinary use.
Shared-stock scenario: one product, two workbenches
Consider a UK laboratory where two colleagues share a BPC-157 10mg stock vial and a second working aliquot is planned for a different assay day. If the shared folder contains a file called “BPC-157 CoA” but the vial label reads BPC10-03/27, the folder name is not enough. The custodian should locate the CoA whose reference matches the vial, rename the file with the full reference, and add both colleagues to the custody line. If the CoA cannot be matched, the stock should be treated as unavailable for assay use until the documentation is reconciled.
Resolve Mismatches and Hand Over Documentation Without Guesswork
When a label reference does not match the available CoA, stop the handover rather than finding a plausible explanation. Quarantine the vial physically and mark it as “documentation pending” in the shared register. Do not open, reconstitute or subdivide the stock until the reference is resolved. Compare the label with the order confirmation, packing documentation, CoA file name and any supplier correspondence. Research Sciences advises quoting the vial reference when contacting the shop about documentation, which is more useful than sending a product name alone because it points to the batch record rather than the catalogue listing.
The investigation should have one owner. If two colleagues share the stock, one person should be responsible for locating the correct CoA or contacting the supplier, while the other agrees not to draw from the vial in the meantime. Check whether the CoA is stored under a legacy product name or an older folder, but do not treat a similar product name as a match. Do not use cap colour, vial size or handwriting on a secondary label as proof of identity. If a secondary label is needed for laboratory traceability, it should preserve the original reference and state that the original label remains the primary identifier.
Where the CoA is present but the batch details look unfamiliar, read the actual document rather than relying on a remembered purity figure. The homepage’s “≥99% Verified Purity” and “3,000+ UK Orders” lines are published marketing wording at the time of writing, not a substitute for batch-level confirmation. The same discipline applies to the homepage statement “CoAs Janoshik Analytical Reports”: open and check the CoA that accompanies the specific batch. If the document cannot be verified, ask for the batch CoA rather than accepting a catalogue page as proof.
Finally, record the resolution in the shared register: what was checked, which CoA now matches the vial, who confirmed it and when the stock was released for laboratory use. Keep the original CoA with the stock record and give both colleagues read access to the same controlled copy. Until reconciliation is complete, the vial should remain unavailable for in-vitro work. This protects the shared stock, the documentation trail and the reproducibility of the research, while keeping handling within the supplier’s research-use-only framework and the laboratory’s own COSHH and safety procedures.
Raised between Amman and Abu Dhabi, Farah is an electrical engineer who swapped circuit boards for keyboards. She’s covered subjects from AI ethics to desert gardening and loves translating tech jargon into human language. Farah recharges by composing oud melodies and trying every new bubble-tea flavor she finds.